1
|
Abubakar ML, Kapoor N, Sharma A, Gambhir L, Jasuja ND, Sharma G. Artificial Intelligence in Drug Identification and Validation: A Scoping Review. Drug Res (Stuttg) 2024; 74:208-219. [PMID: 38830370 DOI: 10.1055/a-2306-8311] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/05/2024]
Abstract
The end-to-end process in the discovery of drugs involves therapeutic candidate identification, validation of identified targets, identification of hit compound series, lead identification and optimization, characterization, and formulation and development. The process is lengthy, expensive, tedious, and inefficient, with a large attrition rate for novel drug discovery. Today, the pharmaceutical industry is focused on improving the drug discovery process. Finding and selecting acceptable drug candidates effectively can significantly impact the price and profitability of new medications. Aside from the cost, there is a need to reduce the end-to-end process time, limiting the number of experiments at various stages. To achieve this, artificial intelligence (AI) has been utilized at various stages of drug discovery. The present study aims to identify the recent work that has developed AI-based models at various stages of drug discovery, identify the stages that need more concern, present the taxonomy of AI methods in drug discovery, and provide research opportunities. From January 2016 to September 1, 2023, the study identified all publications that were cited in the electronic databases including Scopus, NCBI PubMed, MEDLINE, Anthropology Plus, Embase, APA PsycInfo, SOCIndex, and CINAHL. Utilising a standardized form, data were extracted, and presented possible research prospects based on the analysis of the extracted data.
Collapse
Affiliation(s)
| | - Neha Kapoor
- School of Applied Sciences, Suresh Gyan Vihar University, Jaipur, Rajasthan, India
| | - Asha Sharma
- Department of Zoology, Swargiya P. N. K. S. Govt. PG College, Dausa, Rajasthan, India
| | - Lokesh Gambhir
- School of Basic and Applied Sciences, Shri Guru Ram Rai University, Dehradun, Uttarakhand, India
| | | | - Gaurav Sharma
- School of Applied Sciences, Suresh Gyan Vihar University, Jaipur, Rajasthan, India
| |
Collapse
|
2
|
Qiu X, Wang H, Tan X, Fang Z. G-K BertDTA: A graph representation learning and semantic embedding-based framework for drug-target affinity prediction. Comput Biol Med 2024; 173:108376. [PMID: 38552281 DOI: 10.1016/j.compbiomed.2024.108376] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/21/2023] [Revised: 03/21/2024] [Accepted: 03/24/2024] [Indexed: 04/17/2024]
Abstract
Developing new drugs is costly, time-consuming, and risky. Drug-target affinity (DTA), indicating the binding capability between drugs and target proteins, is a crucial indicator for drug development. Accurately predicting interaction strength between new drug-target pairs by analyzing previous experiments aids in screening potential drug molecules, repurposing them, and developing safe and effective medicines. Existing computational models for DTA prediction rely on strings or single-graph neural networks, lacking consideration of protein structure and molecular semantic information, leading to limited accuracy. Our experiments demonstrate that string-based methods may overlook protein conformations, causing a high root mean square error (RMSE) of 3.584 in affinity due to a lack of spatial context. Single graph networks also underperform on topology features, with a 6% lower confidence interval (CI) for activity classification. Absent semantic information also limits generalization across diverse compounds, resulting in 18% increment in RMSE and 5% in misclassifications within quantifications study, restricting potential drug discovery. To address these limitations, we propose G-K BertDTA, a novel framework for accurate DTA prediction incorporating protein features, molecular semantic features, and molecular structural information. In this proposed model, we represent drugs as graphs, with a GIN employed to learn the molecular topological information. For the extraction of protein structural features, we utilize a DenseNet architecture. A knowledge-based BERT semantic model is incorporated to obtain rich pre-trained semantic embeddings, thereby enhancing the feature information. We extensively evaluated our proposed approach on the publicly available benchmark datasets (i.e., KIBA and Davis), and experimental results demonstrate the promising performance of our method, which consistently outperforms previous state-of-the-art approaches. Code is available at https://github.com/AmbitYuki/G-K-BertDTA.
Collapse
Affiliation(s)
- Xihe Qiu
- School of Electronic and Electrical Engineering, Shanghai University of Engineering Science, Shanghai, China
| | - Haoyu Wang
- School of Electronic and Electrical Engineering, Shanghai University of Engineering Science, Shanghai, China
| | - Xiaoyu Tan
- INF Technology (Shanghai) Co., Ltd., Shanghai, China
| | - Zhijun Fang
- School of Computer Science and Technology, Donghua University, Shanghai, China.
| |
Collapse
|
3
|
Gao M, Zhang D, Chen Y, Zhang Y, Wang Z, Wang X, Li S, Guo Y, Webb GI, Nguyen ATN, May L, Song J. GraphormerDTI: A graph transformer-based approach for drug-target interaction prediction. Comput Biol Med 2024; 173:108339. [PMID: 38547658 DOI: 10.1016/j.compbiomed.2024.108339] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/19/2023] [Revised: 03/05/2024] [Accepted: 03/17/2024] [Indexed: 04/17/2024]
Abstract
The application of Artificial Intelligence (AI) to screen drug molecules with potential therapeutic effects has revolutionized the drug discovery process, with significantly lower economic cost and time consumption than the traditional drug discovery pipeline. With the great power of AI, it is possible to rapidly search the vast chemical space for potential drug-target interactions (DTIs) between candidate drug molecules and disease protein targets. However, only a small proportion of molecules have labelled DTIs, consequently limiting the performance of AI-based drug screening. To solve this problem, a machine learning-based approach with great ability to generalize DTI prediction across molecules is desirable. Many existing machine learning approaches for DTI identification failed to exploit the full information with respect to the topological structures of candidate molecules. To develop a better approach for DTI prediction, we propose GraphormerDTI, which employs the powerful Graph Transformer neural network to model molecular structures. GraphormerDTI embeds molecular graphs into vector-format representations through iterative Transformer-based message passing, which encodes molecules' structural characteristics by node centrality encoding, node spatial encoding and edge encoding. With a strong structural inductive bias, the proposed GraphormerDTI approach can effectively infer informative representations for out-of-sample molecules and as such, it is capable of predicting DTIs across molecules with an exceptional performance. GraphormerDTI integrates the Graph Transformer neural network with a 1-dimensional Convolutional Neural Network (1D-CNN) to extract the drugs' and target proteins' representations and leverages an attention mechanism to model the interactions between them. To examine GraphormerDTI's performance for DTI prediction, we conduct experiments on three benchmark datasets, where GraphormerDTI achieves a superior performance than five state-of-the-art baselines for out-of-molecule DTI prediction, including GNN-CPI, GNN-PT, DeepEmbedding-DTI, MolTrans and HyperAttentionDTI, and is on a par with the best baseline for transductive DTI prediction. The source codes and datasets are publicly accessible at https://github.com/mengmeng34/GraphormerDTI.
Collapse
Affiliation(s)
- Mengmeng Gao
- School of Biological Science and Medical Engineering, Southeast University, Nanjing, China
| | - Daokun Zhang
- Department of Data Science and Artificial Intelligence, Faculty of Information Technology, Monash University, Melbourne, Australia.
| | - Yi Chen
- School of Biological Science and Medical Engineering, Southeast University, Nanjing, China.
| | - Yiwen Zhang
- Climate, Air Quality Research Unit, School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, 3004, Australia
| | - Zhikang Wang
- Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Melbourne, Australia
| | - Xiaoyu Wang
- Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Melbourne, Australia
| | - Shanshan Li
- Climate, Air Quality Research Unit, School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, 3004, Australia
| | - Yuming Guo
- Climate, Air Quality Research Unit, School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, 3004, Australia
| | - Geoffrey I Webb
- Department of Data Science and Artificial Intelligence, Faculty of Information Technology, Monash University, Melbourne, Australia
| | - Anh T N Nguyen
- Drug Discovery Biology Theme, Monash Institute of Pharmaceutical Sciences, Monash University, Melbourne, Australia
| | - Lauren May
- Drug Discovery Biology Theme, Monash Institute of Pharmaceutical Sciences, Monash University, Melbourne, Australia
| | - Jiangning Song
- Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Melbourne, Australia.
| |
Collapse
|
4
|
J SG, P D, P E. Enhancing drug discovery in schizophrenia: a deep learning approach for accurate drug-target interaction prediction - DrugSchizoNet. Comput Methods Biomech Biomed Engin 2024:1-18. [PMID: 38375638 DOI: 10.1080/10255842.2023.2282951] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/01/2023] [Accepted: 10/17/2023] [Indexed: 02/21/2024]
Abstract
Drug discovery relies on the precise prognosis of drug-target interactions (DTI). Due to their ability to learn from raw data, deep learning (DL) methods have displayed outstanding performance over traditional approaches. However, challenges such as imbalanced data, noise, poor generalization, high cost, and time-consuming processes hinder progress in this field. To overcome the above challenges, we propose a DL-based model termed DrugSchizoNet for drug interaction (DI) prediction of Schizophrenia. Our model leverages drug-related data from the DrugBank and repoDB databases, employing three key preprocessing techniques. First, data cleaning eliminates duplicate or incomplete entries to ensure data integrity. Next, normalization is performed to enhance security and reduce costs associated with data acquisition. Finally, feature extraction is applied to improve the quality of input data. The three layers of the DrugSchizoNet model are the input, hidden and output layers. In the hidden layer, we employ dropout regularization to mitigate overfitting and improve generalization. The fully connected (FC) layer extracts relevant features, while the LSTM layer captures the sequential nature of DIs. In the output layer, our model provides confidence scores for potential DIs. To optimize the prediction accuracy, we utilize hyperparameter tuning through OB-MOA optimization. Experimental results demonstrate that DrugSchizoNet achieves a superior accuracy of 98.70%. The existing models, including CNN-RNN, DANN, CKA-MKL, DGAN, and CNN, across various evaluation metrics such as accuracy, recall, specificity, precision, F1 score, AUPR, and AUROC are compared with the proposed model. By effectively addressing the challenges of imbalanced data, noise, poor generalization, high cost and time-consuming processes, DrugSchizoNet offers a promising approach for accurate DTI prediction in Schizophrenia. Its superior performance demonstrates the potential of DL in advancing drug discovery and development processes.
Collapse
Affiliation(s)
- Sherine Glory J
- Department of Computer Science and Engineering, SRM Institute of Science and Technology, Vadapalani Campus, Chennai, India
| | - Durgadevi P
- Department of Computer Science and Engineering, SRM Institute of Science and Technology, Vadapalani Campus, Chennai, India
| | - Ezhumalai P
- Department of Computer Science and Engineering, R.M.D. Engineering College, Kavaraipettai, India
| |
Collapse
|
5
|
Xu W, Yang X, Guan Y, Cheng X, Wang Y. Integrative approach for predicting drug-target interactions via matrix factorization and broad learning systems. MATHEMATICAL BIOSCIENCES AND ENGINEERING : MBE 2024; 21:2608-2625. [PMID: 38454698 DOI: 10.3934/mbe.2024115] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 03/09/2024]
Abstract
In the drug discovery process, time and costs are the most typical problems resulting from the experimental screening of drug-target interactions (DTIs). To address these limitations, many computational methods have been developed to achieve more accurate predictions. However, identifying DTIs mostly rely on separate learning tasks with drug and target features that neglect interaction representation between drugs and target. In addition, the lack of these relationships may lead to a greatly impaired performance on the prediction of DTIs. Aiming at capturing comprehensive drug-target representations and simplifying the network structure, we propose an integrative approach with a convolution broad learning system for the DTI prediction (ConvBLS-DTI) to reduce the impact of the data sparsity and incompleteness. First, given the lack of known interactions for the drug and target, the weighted K-nearest known neighbors (WKNKN) method was used as a preprocessing strategy for unknown drug-target pairs. Second, a neighborhood regularized logistic matrix factorization (NRLMF) was applied to extract features of updated drug-target interaction information, which focused more on the known interaction pair parties. Then, a broad learning network incorporating a convolutional neural network was established to predict DTIs, which can make classification more effective using a different perspective. Finally, based on the four benchmark datasets in three scenarios, the ConvBLS-DTI's overall performance out-performed some mainstream methods. The test results demonstrate that our model achieves improved prediction effect on the area under the receiver operating characteristic curve and the precision-recall curve.
Collapse
Affiliation(s)
- Wanying Xu
- College of Computer Science & Technology, Qingdao University, Qingdao 266071, China
| | - Xixin Yang
- College of Computer Science & Technology, Qingdao University, Qingdao 266071, China
- School of Automation, Qingdao University, Qingdao 266071, China
| | - Yuanlin Guan
- Key Lab of Industrial Fluid Energy Conservation and Pollution Control, Ministry of Education, Qingdao University of Technology, Qingdao 266520, China
- School of Mechanical & Automotive Engineering, Qingdao University of Technology, Qingdao 266520, China
| | - Xiaoqing Cheng
- College of Computer Science & Technology, Qingdao University, Qingdao 266071, China
| | - Yu Wang
- College of Computer Science & Technology, Qingdao University, Qingdao 266071, China
| |
Collapse
|
6
|
Huang L, Chen Q, Lan W. Predicting drug-drug interactions based on multi-view and multichannel attention deep learning. Health Inf Sci Syst 2023; 11:50. [PMID: 37941825 PMCID: PMC10628064 DOI: 10.1007/s13755-023-00250-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/18/2023] [Accepted: 09/25/2023] [Indexed: 11/10/2023] Open
Abstract
Predicting drug-drug interactions (DDIs) has become a major concern in the drug research field because it helps explore the pharmacological function of drugs and enables the development of new therapeutic drugs. Existing prediction methods simply integrate multiple drug attributes or perform tasks on a biomedical knowledge graph (KG). Though effective, few methods can fully utilize multi-source drug data information. In this paper, a multi-view and multichannel attention deep learning (MMADL) model is proposed, which not only extracts rich drug features containing both drug attributes and drug-related entity information from multi-source databases, but also considers the consistency and complementarity of different drug feature representation learning approaches to improve the effectiveness and accuracy of DDI prediction. A single-layer perceptron encoder is applied to encode multi-source drug information to obtain multi-view drug representation vectors in the same linear space. Then, the multichannel attention mechanism is introduced to obtain the attention weight by adaptively learning the importance of drug features according to their contributions to DDI prediction. Further, the representation vectors of multi-view drug pairs with attention weights are used as inputs of the deep neural network to predict potential DDI. The accuracy and precision-recall curves of MMADL are 93.05 and 95.94, respectively. The results indicate that the proposed method outperforms other state-of-the-art methods.
Collapse
Affiliation(s)
- Liyu Huang
- School of Computer Science and Engineering, South China University of Technology, Guangzhou, 510006 China
| | - Qingfeng Chen
- School of Computer, Electronics and Information, Guangxi University, Nanning, 530004 China
- Department of Computer Science and Information Technology, La Trobe University, Melbourne, 3086 Australia
| | - Wei Lan
- School of Computer, Electronics and Information, Guangxi University, Nanning, 530004 China
| |
Collapse
|
7
|
Murray JD, Lange JJ, Bennett-Lenane H, Holm R, Kuentz M, O'Dwyer PJ, Griffin BT. Advancing algorithmic drug product development: Recommendations for machine learning approaches in drug formulation. Eur J Pharm Sci 2023; 191:106562. [PMID: 37562550 DOI: 10.1016/j.ejps.2023.106562] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/15/2023] [Revised: 07/09/2023] [Accepted: 08/07/2023] [Indexed: 08/12/2023]
Abstract
Artificial intelligence is a rapidly expanding area of research, with the disruptive potential to transform traditional approaches in the pharmaceutical industry, from drug discovery and development to clinical practice. Machine learning, a subfield of artificial intelligence, has fundamentally transformed in silico modelling and has the capacity to streamline clinical translation. This paper reviews data-driven modelling methodologies with a focus on drug formulation development. Despite recent advances, there is limited modelling guidance specific to drug product development and a trend towards suboptimal modelling practices, resulting in models that may not give reliable predictions in practice. There is an overwhelming focus on benchtop experimental outcomes obtained for a specific modelling aim, leaving the capabilities of data scraping or the use of combined modelling approaches yet to be fully explored. Moreover, the preference for high accuracy can lead to a reliance on black box methods over interpretable models. This further limits the widespread adoption of machine learning as black boxes yield models that cannot be easily understood for the purposes of enhancing product performance. In this review, recommendations for conducting machine learning research for drug product development to ensure trustworthiness, transparency, and reliability of the models produced are presented. Finally, possible future directions on how research in this area might develop are discussed to aim for models that provide useful and robust guidance to formulators.
Collapse
Affiliation(s)
- Jack D Murray
- School of Pharmacy, University College Cork, Cork, Ireland
| | - Justus J Lange
- School of Pharmacy, University College Cork, Cork, Ireland; Roche Pharmaceutical Research & Early Development, Pre-Clinical CMC, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, Basel, Switzerland
| | | | - René Holm
- Department of Physics, Chemistry and Pharmacy, University of Southern Denmark, Campusvej 55, Odense 5230, Denmark
| | - Martin Kuentz
- School of Life Sciences, University of Applied Sciences and Arts Northwestern Switzerland, Muttenz CH 4132, Switzerland
| | | | | |
Collapse
|
8
|
Ye Q, Zhang X, Lin X. Drug-Target Interaction Prediction via Graph Auto-Encoder and Multi-Subspace Deep Neural Networks. IEEE/ACM TRANSACTIONS ON COMPUTATIONAL BIOLOGY AND BIOINFORMATICS 2023; 20:2647-2658. [PMID: 36107905 DOI: 10.1109/tcbb.2022.3206907] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/15/2023]
Abstract
Computational prediction of drug-target interaction (DTI) is important for the new drug discovery. Currently, the deep neural network (DNN) has been widely used in DTI prediction. However, parameters of the DNN could be insufficiently trained and features of the data could be insufficiently utilized, because the DTI data is limited and its dimension is very high. To deal with the above problems, in this paper, a graph auto-encoder and multi-subspace deep neural network (GAEMSDNN) is designed. GAEMSDNN enhances its learning ability with a graph auto-encoder, a subspace layer and an ensemble layer. The graph auto-encoder can preserve the reconstruction information. The subspace layer can obtain different strong feature subsets. The ensemble layer in the GAEMSDNN can comprehensively utilize these strong feature subsets in a unified optimization framework. As a result, more features can be extracted from the network input and the DNN network can be better trained. In experiments, the results of GAEMSDNN are significantly improved compared to the previous methods, which validates the effectiveness of our strategies.
Collapse
|
9
|
Abbasi Mesrabadi H, Faez K, Pirgazi J. Drug-target interaction prediction based on protein features, using wrapper feature selection. Sci Rep 2023; 13:3594. [PMID: 36869062 PMCID: PMC9984486 DOI: 10.1038/s41598-023-30026-y] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/19/2022] [Accepted: 02/14/2023] [Indexed: 03/05/2023] Open
Abstract
Drug-target interaction prediction is a vital stage in drug development, involving lots of methods. Experimental methods that identify these relationships on the basis of clinical remedies are time-taking, costly, laborious, and complex introducing a lot of challenges. One group of new methods is called computational methods. The development of new computational methods which are more accurate can be preferable to experimental methods, in terms of total cost and time. In this paper, a new computational model to predict drug-target interaction (DTI), consisting of three phases, including feature extraction, feature selection, and classification is proposed. In feature extraction phase, different features such as EAAC, PSSM and etc. would be extracted from sequence of proteins and fingerprint features from drugs. These extracted features would then be combined. In the next step, one of the wrapper feature selection methods named IWSSR, due to the large amount of extracted data, is applied. The selected features are then given to rotation forest classification, to have a more efficient prediction. Actually, the innovation of our work is that we extract different features; and then select features by the use of IWSSR. The accuracy of the rotation forest classifier based on tenfold on the golden standard datasets (enzyme, ion channels, G-protein-coupled receptors, nuclear receptors) is as follows: 98.12, 98.07, 96.82, and 95.64. The results of experiments indicate that the proposed model has an acceptable rate in DTI prediction and is compatible with the proposed methods in other papers.
Collapse
Affiliation(s)
- Hengame Abbasi Mesrabadi
- Faculty of Computer and Information Technology Engineering, Qazvin Branch, Islamic Azad University, Qazvin, Iran
| | - Karim Faez
- Department of Electrical Engineering, Amirkabir University of Technology (Tehran Polytechnic), Tehran, Iran.
| | - Jamshid Pirgazi
- Department of Computer Engineering, University of Science and Technology of Mazandaran, Behshahr, Iran
| |
Collapse
|
10
|
SuHAN: Substructural hierarchical attention network for molecular representation. J Mol Graph Model 2023; 119:108401. [PMID: 36584590 DOI: 10.1016/j.jmgm.2022.108401] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/03/2022] [Revised: 12/16/2022] [Accepted: 12/23/2022] [Indexed: 12/26/2022]
Abstract
Recently, molecular representation and property exploration, with the combination of neural network, play a critical role in the field of drug design and discovery for assisting in drug related research. However, previous research in molecular representation relies heavily on artificial extraction of features based on biological experiments which may result in a manually introduced noise of molecular information with high cost in time and money. In this paper, a novel method named Substructural Hierarchical Attention Network (SuHAN) is proposed to discover inherent characteristics of molecules for representation learning. Specifically, SuHAN is composed of the cascaded layer: atom-level layer and substructure-level layer. Molecule in the SMILES format is divided into several substructural fragments by predefined partition rules, and then they are fed into atom-level layer and substructure-level layer successively to obtain feature representation from different perspective: atomic view and substructural view. In this way, the prominent structural features that may be omitted in global extraction are excavated from a fine-grained viewpoint and fused to reconstruct representative pattern in an overall view. Experiments on biophysics and physiology datasets demonstrate that our model is competitive with a significant improvement of both accuracy and stability in performance. We confirmed that the substructural segments and progressive hierarchical networks lead to an effective molecular representation for downstream tasks. These results provide a novel perspective about reconstructing overall pattern through local prominent structure.
Collapse
|
11
|
A Novel Autoencoder-Based Feature Selection Method for Drug-Target Interaction Prediction with Human-Interpretable Feature Weights. Symmetry (Basel) 2023. [DOI: 10.3390/sym15010192] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/11/2023] Open
Abstract
Drug-target interaction prediction provides important information that could be exploited for drug discovery, drug design, and drug repurposing. Chemogenomic approaches for predicting drug-target interaction assume that similar receptors bind to similar ligands. Capturing this similarity in so-called “fingerprints” and combining the target and ligand fingerprints provide an efficient way to search for protein-ligand pairs that are more likely to interact. In this study, we constructed drug and target fingerprints by employing features extracted from the DrugBank. However, the number of extracted features is quite large, necessitating an effective feature selection mechanism since some features can be redundant or irrelevant to drug-target interaction prediction problems. Although such feature selection methods are readily available in the literature, usually they act as black boxes and do not provide any quantitative information about why a specific feature is preferred over another. To alleviate this lack of human interpretability, we proposed a novel feature selection method in which we used an autoencoder as a symmetric learning method and compared the proposed method to some popular feature selection algorithms, such as Kbest, Variance Threshold, and Decision Tree. The results of a detailed performance study, in which we trained six Multi-Layer Perceptron (MLP) Networks of different sizes and configurations for prediction, demonstrate that the proposed method yields superior results compared to the aforementioned methods.
Collapse
|
12
|
Krithika alias AnbuDevi M, Suganthi K. Review of Semantic Segmentation of Medical Images Using Modified Architectures of UNET. Diagnostics (Basel) 2022; 12:diagnostics12123064. [PMID: 36553071 PMCID: PMC9777361 DOI: 10.3390/diagnostics12123064] [Citation(s) in RCA: 9] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/08/2022] [Revised: 11/17/2022] [Accepted: 11/22/2022] [Indexed: 12/12/2022] Open
Abstract
In biomedical image analysis, information about the location and appearance of tumors and lesions is indispensable to aid doctors in treating and identifying the severity of diseases. Therefore, it is essential to segment the tumors and lesions. MRI, CT, PET, ultrasound, and X-ray are the different imaging systems to obtain this information. The well-known semantic segmentation technique is used in medical image analysis to identify and label regions of images. The semantic segmentation aims to divide the images into regions with comparable characteristics, including intensity, homogeneity, and texture. UNET is the deep learning network that segments the critical features. However, UNETs basic architecture cannot accurately segment complex MRI images. This review introduces the modified and improved models of UNET suitable for increasing segmentation accuracy.
Collapse
|
13
|
Zeng Y, Chen X, Peng D, Zhang L, Huang H. Multi-scaled self-attention for drug-target interaction prediction based on multi-granularity representation. BMC Bioinformatics 2022; 23:314. [PMID: 35922768 PMCID: PMC9347097 DOI: 10.1186/s12859-022-04857-x] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/23/2022] [Accepted: 07/22/2022] [Indexed: 11/21/2022] Open
Abstract
Background Drug–target interaction (DTI) prediction plays a crucial role in drug discovery. Although the advanced deep learning has shown promising results in predicting DTIs, it still needs improvements in two aspects: (1) encoding method, in which the existing encoding method, character encoding, overlooks chemical textual information of atoms with multiple characters and chemical functional groups; as well as (2) the architecture of deep model, which should focus on multiple chemical patterns in drug and target representations. Results In this paper, we propose a multi-granularity multi-scaled self-attention (SAN) model by alleviating the above problems. Specifically, in process of encoding, we investigate a segmentation method for drug and protein sequences and then label the segmented groups as the multi-granularity representations. Moreover, in order to enhance the various local patterns in these multi-granularity representations, a multi-scaled SAN is built and exploited to generate deep representations of drugs and targets. Finally, our proposed model predicts DTIs based on the fusion of these deep representations. Our proposed model is evaluated on two benchmark datasets, KIBA and Davis. The experimental results reveal that our proposed model yields better prediction accuracy than strong baseline models. Conclusion Our proposed multi-granularity encoding method and multi-scaled SAN model improve DTI prediction by encoding the chemical textual information of drugs and targets and extracting their various local patterns, respectively.
Collapse
Affiliation(s)
- Yuni Zeng
- School of Information Science and Technology, Zhejiang Sci-Tech University, Hangzhou, China
| | - Xiangru Chen
- College of Computer Science, Sichuan University, Chengdu, China
| | - Dezhong Peng
- College of Computer Science, Sichuan University, Chengdu, China.,Shenzhen Peng Cheng Laboratory, Shenzhen, China.,Chengdu Sobey Digital Technology Co., Ltd, Chengdu, China
| | - Lijun Zhang
- Sichuan Zhiqian Technology Co., Ltd, Chengdu, China.,Chengdu Ruibei Yingte Information Technology Co., Ltd, Chengdu, China
| | - Haixiao Huang
- Sichuan Provincial Commission of Politics and Law, Chengdu, China.
| |
Collapse
|
14
|
Monteiro NR, Oliveira JL, Arrais JP. DTITR: End-to-end drug–target binding affinity prediction with transformers. Comput Biol Med 2022; 147:105772. [DOI: 10.1016/j.compbiomed.2022.105772] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/07/2022] [Revised: 06/07/2022] [Accepted: 06/19/2022] [Indexed: 11/03/2022]
|
15
|
Detecting Drug–Target Interactions with Feature Similarity Fusion and Molecular Graphs. BIOLOGY 2022; 11:biology11070967. [PMID: 36101348 PMCID: PMC9312204 DOI: 10.3390/biology11070967] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 05/10/2022] [Revised: 06/12/2022] [Accepted: 06/24/2022] [Indexed: 12/03/2022]
Abstract
Simple Summary Accurate identification of potential targets for drugs to interact with can accelerate drug development. The identification of drug–target interactions can provide insights into hidden drug efficacy. This paper presents a prediction model based on feature similarity fusion that can identify crucial features of drugs and targets to help predict drug–target interactions. Abstract The key to drug discovery is the identification of a target and a corresponding drug compound. Effective identification of drug–target interactions facilitates the development of drug discovery. In this paper, drug similarity and target similarity are considered, and graphical representations are used to extract internal structural information and intermolecular interaction information about drugs and targets. First, drug similarity and target similarity are fused using the similarity network fusion (SNF) method. Then, the graph isomorphic network (GIN) is used to extract the features with information about the internal structure of drug molecules. For target proteins, feature extraction is carried out using TextCNN to efficiently capture the features of target protein sequences. Three different divisions (CVD, CVP, CVT) are used on the standard dataset, and experiments are carried out separately to validate the performance of the model for drug–target interaction prediction. The experimental results show that our method achieves better results on AUC and AUPR. The docking results also show the superiority of the proposed model in predicting drug–target interactions.
Collapse
|
16
|
Wang F, Lei X, Liao B, Wu FX. Predicting drug-drug interactions by graph convolutional network with multi-kernel. Brief Bioinform 2021; 23:6447677. [PMID: 34864856 DOI: 10.1093/bib/bbab511] [Citation(s) in RCA: 16] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/14/2021] [Revised: 10/28/2021] [Accepted: 11/07/2021] [Indexed: 11/14/2022] Open
Abstract
Drug repositioning is proposed to find novel usages for existing drugs. Among many types of drug repositioning approaches, predicting drug-drug interactions (DDIs) helps explore the pharmacological functions of drugs and achieves potential drugs for novel treatments. A number of models have been applied to predict DDIs. The DDI network, which is constructed from the known DDIs, is a common part in many of the existing methods. However, the functions of DDIs are different, and thus integrating them in a single DDI graph may overlook some useful information. We propose a graph convolutional network with multi-kernel (GCNMK) to predict potential DDIs. GCNMK adopts two DDI graph kernels for the graph convolutional layers, namely, increased DDI graph consisting of 'increase'-related DDIs and decreased DDI graph consisting of 'decrease'-related DDIs. The learned drug features are fed into a block with three fully connected layers for the DDI prediction. We compare various types of drug features, whereas the target feature of drugs outperforms all other types of features and their concatenated features. In comparison with three different DDI prediction methods, our proposed GCNMK achieves the best performance in terms of area under receiver operating characteristic curve and area under precision-recall curve. In case studies, we identify the top 20 potential DDIs from all unknown DDIs, and the top 10 potential DDIs from the unknown DDIs among breast, colorectal and lung neoplasms-related drugs. Most of them have evidence to support the existence of their interactions. fangxiang.wu@usask.ca.
Collapse
Affiliation(s)
- Fei Wang
- Division of Biomedical Engineering, University of Saskatchewan, 57 Campus Drive, S7N 5A9, Saskatchewan, Canada
| | - Xiujuan Lei
- School of Computer Science, Shaanxi Normal University, 620 West Chang'an Avenue, 710119, Shaanxi, China
| | - Bo Liao
- School of Mathematics and Statistics, Hainan Normal University, 99 Longkun South Road, 571158, Hainan, China
| | - Fang-Xiang Wu
- Division of Biomedical Engineering, University of Saskatchewan, 57 Campus Drive, S7N 5A9, Saskatchewan, Canada
- Department of Mechanical Engineering and Department of Computer Science, University of Saskatchewan, 57 Campus Drive, S7N 5A9, Saskatchewan, Canada
| |
Collapse
|
17
|
Sorkhi AG, Abbasi Z, Mobarakeh MI, Pirgazi J. Drug-target interaction prediction using unifying of graph regularized nuclear norm with bilinear factorization. BMC Bioinformatics 2021; 22:555. [PMID: 34789169 PMCID: PMC8597250 DOI: 10.1186/s12859-021-04464-2] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/26/2020] [Accepted: 10/29/2021] [Indexed: 12/27/2022] Open
Abstract
BACKGROUND Wet-lab experiments for identification of interactions between drugs and target proteins are time-consuming, costly and labor-intensive. The use of computational prediction of drug-target interactions (DTIs), which is one of the significant points in drug discovery, has been considered by many researchers in recent years. It also reduces the search space of interactions by proposing potential interaction candidates. RESULTS In this paper, a new approach based on unifying matrix factorization and nuclear norm minimization is proposed to find a low-rank interaction. In this combined method, to solve the low-rank matrix approximation, the terms in the DTI problem are used in such a way that the nuclear norm regularized problem is optimized by a bilinear factorization based on Rank-Restricted Soft Singular Value Decomposition (RRSSVD). In the proposed method, adjacencies between drugs and targets are encoded by graphs. Drug-target interaction, drug-drug similarity, target-target, and combination of similarities have also been used as input. CONCLUSIONS The proposed method is evaluated on four benchmark datasets known as Enzymes (E), Ion channels (ICs), G protein-coupled receptors (GPCRs) and nuclear receptors (NRs) based on AUC, AUPR, and time measure. The results show an improvement in the performance of the proposed method compared to the state-of-the-art techniques.
Collapse
Affiliation(s)
- Ali Ghanbari Sorkhi
- Faculty of Electrical and Computer Engineering, University of Science and Technology of Mazandaran, P.O. Box, 48518-78195 Behshahr, Iran
| | - Zahra Abbasi
- School of Medicine, Faculty of Medical Biotechnology, Shahroud University of Medical Sciences, Shahroud, Iran
| | | | - Jamshid Pirgazi
- Faculty of Electrical and Computer Engineering, University of Science and Technology of Mazandaran, P.O. Box, 48518-78195 Behshahr, Iran
| |
Collapse
|
18
|
Vatansever S, Schlessinger A, Wacker D, Kaniskan HÜ, Jin J, Zhou M, Zhang B. Artificial intelligence and machine learning-aided drug discovery in central nervous system diseases: State-of-the-arts and future directions. Med Res Rev 2021; 41:1427-1473. [PMID: 33295676 PMCID: PMC8043990 DOI: 10.1002/med.21764] [Citation(s) in RCA: 102] [Impact Index Per Article: 34.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/23/2020] [Revised: 10/30/2020] [Accepted: 11/20/2020] [Indexed: 01/11/2023]
Abstract
Neurological disorders significantly outnumber diseases in other therapeutic areas. However, developing drugs for central nervous system (CNS) disorders remains the most challenging area in drug discovery, accompanied with the long timelines and high attrition rates. With the rapid growth of biomedical data enabled by advanced experimental technologies, artificial intelligence (AI) and machine learning (ML) have emerged as an indispensable tool to draw meaningful insights and improve decision making in drug discovery. Thanks to the advancements in AI and ML algorithms, now the AI/ML-driven solutions have an unprecedented potential to accelerate the process of CNS drug discovery with better success rate. In this review, we comprehensively summarize AI/ML-powered pharmaceutical discovery efforts and their implementations in the CNS area. After introducing the AI/ML models as well as the conceptualization and data preparation, we outline the applications of AI/ML technologies to several key procedures in drug discovery, including target identification, compound screening, hit/lead generation and optimization, drug response and synergy prediction, de novo drug design, and drug repurposing. We review the current state-of-the-art of AI/ML-guided CNS drug discovery, focusing on blood-brain barrier permeability prediction and implementation into therapeutic discovery for neurological diseases. Finally, we discuss the major challenges and limitations of current approaches and possible future directions that may provide resolutions to these difficulties.
Collapse
Affiliation(s)
- Sezen Vatansever
- Department of Genetics and Genomic SciencesIcahn School of Medicine at Mount SinaiNew YorkNew YorkUSA
- Mount Sinai Center for Transformative Disease ModelingIcahn School of Medicine at Mount SinaiNew YorkNew YorkUSA
- Icahn Institute for Data Science and Genomic TechnologyIcahn School of Medicine at Mount SinaiNew YorkNew YorkUSA
| | - Avner Schlessinger
- Department of Pharmacological SciencesIcahn School of Medicine at Mount SinaiNew YorkNew YorkUSA
- Mount Sinai Center for Therapeutics DiscoveryIcahn School of Medicine at Mount SinaiNew YorkNew YorkUSA
| | - Daniel Wacker
- Department of Pharmacological SciencesIcahn School of Medicine at Mount SinaiNew YorkNew YorkUSA
- Mount Sinai Center for Therapeutics DiscoveryIcahn School of Medicine at Mount SinaiNew YorkNew YorkUSA
- Department of NeuroscienceIcahn School of Medicine at Mount SinaiNew YorkNew YorkUSA
| | - H. Ümit Kaniskan
- Department of Pharmacological SciencesIcahn School of Medicine at Mount SinaiNew YorkNew YorkUSA
- Mount Sinai Center for Therapeutics DiscoveryIcahn School of Medicine at Mount SinaiNew YorkNew YorkUSA
- Department of Oncological Sciences, Tisch Cancer InstituteIcahn School of Medicine at Mount SinaiNew YorkNew YorkUSA
| | - Jian Jin
- Department of Pharmacological SciencesIcahn School of Medicine at Mount SinaiNew YorkNew YorkUSA
- Mount Sinai Center for Therapeutics DiscoveryIcahn School of Medicine at Mount SinaiNew YorkNew YorkUSA
- Department of Oncological Sciences, Tisch Cancer InstituteIcahn School of Medicine at Mount SinaiNew YorkNew YorkUSA
| | - Ming‐Ming Zhou
- Department of Pharmacological SciencesIcahn School of Medicine at Mount SinaiNew YorkNew YorkUSA
- Department of Oncological Sciences, Tisch Cancer InstituteIcahn School of Medicine at Mount SinaiNew YorkNew YorkUSA
| | - Bin Zhang
- Department of Genetics and Genomic SciencesIcahn School of Medicine at Mount SinaiNew YorkNew YorkUSA
- Mount Sinai Center for Transformative Disease ModelingIcahn School of Medicine at Mount SinaiNew YorkNew YorkUSA
- Icahn Institute for Data Science and Genomic TechnologyIcahn School of Medicine at Mount SinaiNew YorkNew YorkUSA
- Department of Pharmacological SciencesIcahn School of Medicine at Mount SinaiNew YorkNew YorkUSA
| |
Collapse
|
19
|
Cluster Analysis of Medicinal Plants and Targets Based on Multipartite Network. Biomolecules 2021; 11:biom11040546. [PMID: 33917905 PMCID: PMC8068312 DOI: 10.3390/biom11040546] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/25/2021] [Revised: 04/05/2021] [Accepted: 04/06/2021] [Indexed: 01/08/2023] Open
Abstract
Network-based methods for the analysis of drug-target interactions have gained attention and rely on the paradigm that a single drug can act on multiple targets rather than a single target. In this study, we have presented a novel approach to analyze the interactions between the chemicals in the medicinal plants and multiple targets based on the complex multipartite network of the medicinal plants, multi-chemicals, and multiple targets. The multipartite network was constructed via the conjunction of two relationships: chemicals in plants and the biological actions of those chemicals on the targets. In doing so, we introduced an index of the efficacy of chemicals in a plant on a protein target of interest, called target potency score (TPS). We showed that the analysis can identify specific chemical profiles from each group of plants, which can then be employed for discovering new alternative therapeutic agents. Furthermore, specific clusters of plants and chemicals acting on specific targets were retrieved using TPS that suggested potential drug candidates with high probability of clinical success. We expect that this approach may open a way to predict the biological functions of multi-chemicals and multi-plants on the targets of interest and enable repositioning of the plants and chemicals.
Collapse
|
20
|
Abstract
The current global pandemic COVID-19 caused by the SARS-CoV-2 virus has already inflicted insurmountable damage both to the human lives and global economy. There is an immediate need for identification of effective drugs to contain the disastrous virus outbreak. Global efforts are already underway at a war footing to identify the best drug combination to address the disease. In this review, an attempt has been made to understand the SARS-CoV-2 life cycle, and based on this information potential druggable targets against SARS-CoV-2 are summarized. Also, the strategies for ongoing and future drug discovery against the SARS-CoV-2 virus are outlined. Given the urgency to find a definitive cure, ongoing drug repurposing efforts being carried out by various organizations are also described. The unprecedented crisis requires extraordinary efforts from the scientific community to effectively address the issue and prevent further loss of human lives and health.
Collapse
Affiliation(s)
- Ambrish Saxena
- Indian Institute of Technology Tirupati, Tirupati, India
| |
Collapse
|